Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1

Pharmacogenetics

Volumn 9, Issue 1, 1999, Pages 113-121

  Siegel, David ^a   McGuinness, Susan M ^a   Winski, Shannon L ^a   Ross, David ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Chemoprotection; DT diaphorase; Genotype; NAD(P)H:quinone oxidoreductase (NQO1); Phenotype; Polymorphism

Indexed keywords

COMPLEMENTARY DNA; PROLINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SERINE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BONE MARROW; BREAST TUMOR; CHEMOLUMINESCENCE; COLON TUMOR; CONTROLLED STUDY; DNA DETERMINATION; DNA SEQUENCE; ENZYME ACTIVITY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG TUMOR; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SALIVA; STROMA CELL; TUMOR CELL LINE; VASCULAR ENDOTHELIUM;

EID: 0032891702     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199902000-00015     Document Type: Article

References (40)

1. Beall HD, Mulcahy RT, Siegel D, Traver RD, Gibson NW, Ross D. Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases. Cancer Res 1994; 54:3196-3201.
2. Beall HD, Murphy AM, Siegel D, Hargreaves RHJ, Butler J, Ross D. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive anti-tumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines. Mol Pharmacol 1995; 48:499-504.
3. Benson AM, Hunkelerm MJ, Talalay P. Increase of NAD(P)H: quinone reductase by dietary antioxidants. Possible role in protection against carcinogenesis. Proc Natl Acad Sci USA 1980; 77:5216-5220.
4. Beyer RE, Segura-Aguilar J, Di Bernardo S, Cavazzoni M, Fato R, Fiorentini D, et al. The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems. Proc Natl Acad Sci USA 1996; 93:2528-2532.
5. Eickelmann P, Ebert T, Warskulat U, Schulz WA, Sies H. Expression of NAD(P)H: quinone oxidoreductase and glutathione S-transferases a and p in human renal cell carcinoma and in kidney cancer-derived cell lines. Carcinogenesis 1994a; 15:219-225.
6. Eickelmann P, Schulz WA, Rohde D, Schmitz-Dräger B, Sies H. Loss of heterozygosity at the NAD(P)H: quinone oxidoreductase locus associated with increased resistance against mitomycin C in a human bladder carcinoma cell line. Biol Chem Hoppe Seyler 1994b; 375:439-445.
7. Ernster L. DT-diaphorase. Meth Enzymol 1967; 10:309-317.
8. Gartner S, Kaplan HS. Long-term culture of human bone marrow cells. Proc Natl Acad Sci U S A 1980; 77:4756-4759.
9. 3. J Exp Med 1964; 119:923-942.
10. Kelsey KT, Wiencke JK, Christiani DC, Zuo Z. Spitz MR, Xu X, et al. Ethnic variation in the prevalence of a common NAD(P)H: quinone oxidoreductase polymorphism and its implications for anticancer chemotherapy. Br J Cancer 1997; 76:852-854.
11. Kolesar JM, Burris III HA, Kuhn JG. Detection of a point mutation in NQO1 (DT-diaphorase) in a patient with colon cancer. JNCI 1995; 87:1803.
12. Landi L, Fiorentini D, Galli MC, Segura-Aguilar J. Beyer RE. DT-diaphorase maintains the reduced state of ubiquinones in lipid vesicles thereby promoting their antioxidant function. Free Radic Biol Med 1997; 22:329-335.
13. Leith MK, Begleiter A. Mutation of DT-diaphorase in human breast cancer cell lines. Proc Am Assoc Cancer Res 1998; 39:2916.
14. Lind C, Cadenas E, Hochstein P, Ernster L. DT-diaphorase. purification properties and function. Meth Enzymol 1990; 186:287-301.
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275.
16. Malkinson AM, Siegel D, Forrest GL, Gazdar AF, Oie HK, Chan DC, et al. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin C. Cancer Res 1992; 52:4752-4757.
17. Misra V, Klamut HJ, Rauth AM. Transfection of COS-1 cells with DT-diaphorase cDNA: role of a base change at position 609. Br J Cancer 1998; 77:1236-1240.
18. Moran JL, Siegel D, Ross D. Mechanism underlying the increased susceptibility of individuals with a polymorphism in NQO1 to benzene toxicity. Toxicologist 1998; 42 (suppl 1):1393.
19. Pan SS, Forrest GL, Akman SA, Hu L-T. NAD(P)H: quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells. Cancer Res 1995; 55:330-335.
20. Radjendirane V, Joseph P, Lee YH, Kimura S, Klein-Szanto AJP, Gonzalez FJ, Jaiswal AK. Disruption of the DT-diaphorase (NQO1) gene in mice leads to increased menadione toxicity. J Biol Chem 1998; 273:7382-7389.
21. Ross D. Quinone Reductases. In: Guengerich FP, editor. Comprehensive toxicology: biotransformation. Vol. 3. New York: Pergamon, 1997. pp. 179-198.
22. Ross D, Siegel D, Beall H, Prakash AS, Mulcahy RT, Gibson NW. DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C. Cancer Metastasis Rev 1993; 12:83-101.
23. Ross D, Beall H, Traver RD, Siegel D, Phillips RM, Gibson NW. Bioactivation of quinones by DT-diaphorase. Molecular, biochemical and chemical studies. Oncoj Res 1994; 6:493-500.
24. Ross D, Siegel D, Schattenberg DG, Sun XMM, Moran JL. Cell-specific activation and detoxification of benzene metabolites in mouse and human bone marrow: identification of target cells and a potential role for modulation of apoptosis in benzene toxicity. Environ Health Perspect 1996; 104 (suppl 6):1177-1182.
25. Rosvold EA, McGlynn KA, Lustbader ED, Buetow KH. Identification of an NAD(P)H: quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Pharmacogenetics 1995a; 5:199-206.
26. Rosvold EA, McGlynn KA, Lustbader ED, Buetow KH. Detection of a point mutation in NQO1 (DT-diaphorase) in a patient with colon cancer. J Natl Cancer Inst. 1995b; 87:1802-1803.
27. 609C to T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res 1997; 57:2839-2842.
28. Schulz WA, Krummeck A, Rosinger I, Eickelmann P, Neuhas C, Ebert T, et al. Increased frequency of a null allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies. Pharmacogenetics 1997; 7:235-239.
29. Siegel D, Bolton EM, Burr JA, Liebler DC, Ross D. The reduction of alpha-tocopherolquinone by human NAD(P)H: quinone oxidoreductase: the role of alpha-tocopherol hydroquinone as a cellular antioxidant. Mol Pharmacol 1997; 52:300-305.
30. Siegel D, Franklin WA, Ross D. Immunohistochemical staining for NAD(P)H: quinone oxidoreductase (NQO1) in normal lung and lung tumors. Proc Am Assoc Cancer Res 1998; 39:804.
31. Smitskamp-Wilms E, Giaccone G, Pinedo HM, Van der Laan BFAM, Peters GJ. DT-diaphorase activity in normal and neoplastic human tissues; An indicator for sensitivity to bioreductive agents. Br J Cancer 1995; 72:917-921.
32. Sreerama L, Hedge MW, Sladek NE. Identification of a class 3 aldehyde dehydrogenase in human saliva and increased levels of this enzyme, glutathione -S-transferases and DT-diaphorase in the saliva of subjects who continually ingest large quantities of coffee or broccoli. Clin Cancer Res 1995; 1:1153-1163.
33. Talalay P, Benson AM. Elevation of quinone reductase activity by anticarcinogenic antioxidants. Adv Enzyme Regul 1981; 20:287-300.
34. Talalay P, Prochaska HJ. Mechanisms of induction of NAD(P)H: quinone reductase. Chemica Scripta 1987; 27A:61-66.
35. Traver RD, Horikoshi T, Danenberg KD, Stadlbauer THW, Danenberg PV, Ross D, Gibson NW. NAD(P)H: quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res 1992; 52:797-802.
36. Traver RD, Rothman N, Smith MT, Yin SY, Hayes RB, Li GL, et al. Incidence of a polymorphism in NAD(P)H: quinone oxidoreductase (NQO1). Proc Am Assoc Cancer Res 1996; 37:1894.
37. Traver RD, Siegel D, Beall HD, Phillips RM, Gibson NW, Franklin WA, Ross D. Characterization of a polymorphism in NAD(P)H: Quinone oxidoreductase (DT-diaphorase). Br J Cancer 1997; 75:69-75.
38. Wiencke JT. Spitz MR, McMillan A, Kelsey KT. Lung cancer in Mexican-Americans and African-Americans is associated with the wild type genotype of the NAD(P)H: quinone oxidoreductase polymorphism. Cancer Epidemiol Bio Prev 1997; 6:87-92.
39. Wu K, Deng PSK, Chen S. Catalytic properties of a naturally occurring mutant of human NAD(P)H: quinone oxidoreductase (DT-diaphorase). Pro 187 to Ser. Proc Am Assoc Cancer Res 1997; 38:3758.
40. Zhang Y, Talalay P, Cho CG, Posner GH, A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci USA 1992; 89:2399-2403.